Zacks.com on MSN11h
DexCom Stock Rises Despite Q4 Earnings Miss & Lower Margins
DexCom, Inc. DXCM reported fourth-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which missed the Zacks ...
FDA Approves First Rapid-Acting Insulin Biosimilar Product For Treatment Of Diabetes
Agency Continues Efforts to Increase Access to Insulin Treatment Options SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S.
New gene switch activates with simple skin patch and could help treat diabetes
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...